Federal contractor profile
REVAGENIX INC
UEI D98QFZUPFXJ9CAGE 8B1Y9
Active
Small Business
Overview
- Legal name
- REVAGENIX INC
- Also known as
- REVAGENIX INC
- Registered location
- SAN MATEO, CA, USA
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- Latest award activity
- Jul 10, 2026
Read company summary
REVAGENIX INC is associated with UEI D98QFZUPFXJ9 and CAGE 8B1Y9 in public federal records. AcornBids currently links 2 prime awards totaling $55.1M in obligations to this entity. Its largest recorded federal customer by obligations is Department of Health and Human Services. Its recorded federal awards include work classified as Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology). These categories describe the loaded award records, not a complete list of company capabilities. Its primary SAM.gov NAICS is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)). Its public SAM.gov registration lists SAN MATEO, CA, USA.
At a glance
Lifetime prime obligations$55.1M
Prime awards2
Awards with future end dates1
Top-agency concentration
Not available
Why this customer concentration
Detailed agency totals are not available in this stored profile.
Largest positive coded-agency total ÷ all positive coded-agency totals × 100
Missing data is shown as unavailable.
Prime contract obligations across loaded award records. Obligations are not revenue or contract ceilings. Summary updated Oct 9, 2026. Refresh pending; these totals may be out of date.
Business information
Public SAM.gov registration details.
- Legal name
- REVAGENIX INC
- Doing business as
- REVAGENIX INC
- UEI
- D98QFZUPFXJ9
- CAGE
- 8B1Y9
- Registered address
- 1729 DOLAN AVE, SAN MATEO, CA, 94401, USA
- Registration status
- Active
- Primary NAICS
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- SAM activation
- Jan 28, 2026
- Initial registration
- Apr 18, 2019
- Entity start
- Apr 1, 2019
- SAM updated
- Jan 28, 2026
- Registration expires
- Jan 28, 2027
- Fiscal year end
- Dec 31
- Place of incorporation
- DE, USA
Research brief
Source facts
- Loaded prime-award records link 2 awards and $55,112,188 in reported obligations to this legal entity. Source
- Recorded awards include Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (NAICS 541715); this classification is not proof of every company capability. Source
- An example award describes: TO SELECT A NOVEL SMALL MOLECULE ANTIBIOTIC FOR CLINICAL DEVELOPMENT AND ADVANCE IT THROUGH IND FILING AND PHASE 1 CLINICAL STUDIES. Source
Federal award analysis
Net transaction obligations by federal fiscal period.
Selected transaction obligations$55.1M
Prime contracts
Reported transaction obligations by federal fiscal period; includes deobligations. Missing transactions are not estimated. Coverage: 2 of 2 selected awards. Select a period to explore its awards.
Recent federal awards
Prime contract awards. Select an award to review its history and source evidence.
| Award / description | Awarding agency | Obligations | Start date | End date |
|---|---|---|---|---|
| 75N93020C00018TO SELECT A NOVEL SMALL MOLECULE ANTIBIOTIC FOR CLINICAL DEVELOPMENT AND ADVANCE IT THROUGH IND FILING AND PHASE 1 CLINICAL STUDIES. | Department of Health and Human Services | $26.9M | Jul 1, 2020 | Aug 31, 2026 |
| 75N93022C00061A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY. | Department of Health and Human Services | $28.2M | Sep 22, 2022 | Apr 25, 2028 |
Upcoming positioning windows
Modeled recompete windows are estimates, not announced solicitations or guarantees.
Registration, certifications & contacts
| Registration evidence | Date |
|---|---|
| SAM updated | Jan 28, 2026 |
| Source loaded | Sep 26, 2026 |
| Initial registration | Apr 18, 2019 |
| Entity start | Apr 1, 2019 |
Registration classifications: Small Business. These are separate from the reported certificates above.
| Industry | Reported size status |
|---|---|
| 541714 — Research and Development in Biotechnology (except Nanobiotechnology) | Not reported |
| 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) | Not reported |
| Contact | Role | Published contact methods | Evidence | Source date |
|---|---|---|---|---|
| ANDREW MCCANDLISH | Government business | Contact method not published | SAM registration | Not available |
| PAUL BOYER | Alternate government business | Contact method not published | SAM registration | Not available |
| ANDREW MCCANDLISH | Electronic business | Contact method not published | SAM registration | Not available |
| ARTHUR CULANG | Alternate electronic business | Contact method not published | SAM registration | Not available |
Registered industries
- 541714 — Research and Development in Biotechnology (except Nanobiotechnology)
- 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Registered products and services
- AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH
Registration classifications and published certificates do not by themselves establish eligibility for a particular solicitation. View SAM source
Related companies worth researching
Explore the customer, work and award-size evidence behind each match.
1 awards
1 awards
1 awards
About REVAGENIX INC
What products and services appear in its federal awards?
Recorded award industries: 541715 — Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology).
Recorded products and services: AN12 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; APPLIED RESEARCH.
Examples from recent award records:
- TO SELECT A NOVEL SMALL MOLECULE ANTIBIOTIC FOR CLINICAL DEVELOPMENT AND ADVANCE IT THROUGH IND FILING AND PHASE 1 CLINICAL STUDIES.
- A NOVEL LPXC INHIBITOR WITH PAN-RESISTANT PSEUDOMONAS AND BURKHOLDERIA ACTIVITY.
These records describe federal award work, not every company capability. Review the award evidence.
Where is the company registered?
1729 DOLAN AVE, SAN MATEO, California 94401, United States
Registered location from SAM.gov; award performance locations may differ.
What is its primary registered industry?
541714 — Research and Development in Biotechnology (except Nanobiotechnology).
Primary SAM.gov NAICS classification.
Which federal agencies are represented in its awards?
Department of Health and Human Services.
Data coverage and methodology
Sources: SAM.gov registration, USAspending awards and transactions, and linked supporting records. Prime contract obligations, IDV ceilings and assistance amounts are kept separate. Missing records are not zero activity. Company claims are labeled separately. Recompete signals are rule-based scores out of 100. Positioning windows are AcornBids estimates.
Disclosed relationships only. Missing records do not establish that a contractor has no partners. Ambiguous parent award identifiers are excluded.
Recently viewed companies
Keep your research moving
Save this company, track changes, and evaluate upcoming work against your targets.
Save to my research Find my fit